These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833 [TBL] [Abstract][Full Text] [Related]
3. Prioritization of research addressing management strategies for ductal carcinoma in situ. Gierisch JM; Myers ER; Schmit KM; Crowley MJ; McCrory DC; Chatterjee R; Coeytaux RR; Kendrick A; Sanders GD Ann Intern Med; 2014 Apr; 160(7):484-91. PubMed ID: 24567146 [TBL] [Abstract][Full Text] [Related]
4. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283 [TBL] [Abstract][Full Text] [Related]
5. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy. Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S; J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347 [TBL] [Abstract][Full Text] [Related]
8. The implantable cardioverter-defibrillator: An update. Miller JD; Yousuf O; Berger RD Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203 [TBL] [Abstract][Full Text] [Related]
10. Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death. Verkerk AJ; Vermeer AM; Smets EM; Dekker LR; Wilde AA; Van Langen IM; Christiaans I; Nieuwkerk PT Pacing Clin Electrophysiol; 2015 Jul; 38(7):870-7. PubMed ID: 25880250 [TBL] [Abstract][Full Text] [Related]
11. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
12. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111 [TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up. Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378 [TBL] [Abstract][Full Text] [Related]
14. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Herman D; Stros P; Curila K; Kebza V; Osmancik P Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573 [TBL] [Abstract][Full Text] [Related]